Zobrazeno 1 - 10 of 161 pro vyhledávání: '"van Warmerdam LJC"'
1
Akademický článek
Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy - A two center cohort study.
Autor: Schipper RJ; Department of Surgery, Catharina Hospital Eindhoven, the Netherlands; Department of Surgery, Anna Hospital, Geldrop, the Netherlands. Electronic address: info@rjschipper.nl., de Bruijn A; Department of Surgery, Catharina Hospital Eindhoven, the Netherlands., van der Sangen MJC; Department of Radiotherapy, Catharina Hospital Eindhoven, the Netherlands., Bloemen JG; Department of Surgery, Catharina Hospital Eindhoven, the Netherlands., van den Hoven I; Department of Surgery, Anna Hospital, Geldrop, the Netherlands., Schepers EEM; Department of Surgery, Anna Hospital, Geldrop, the Netherlands., Vriens BEP; Department of Internal Medicine, Catharina Hospital Eindhoven, the Netherlands., Boerman T; Department of Pathology, Eurofins PAMM, Veldhoven, the Netherlands., Rijkaart DC; Department of Radiotherapy, Catharina Hospital Eindhoven, the Netherlands., van de Winkel LMH; Department of Internal Medicine, Anna Hospital, Geldrop, the Netherlands., Brouwer C; Department of Nuclear Medicine, Catharina Hospital Eindhoven, the Netherlands., van Warmerdam LJC; Department of Internal Medicine, Catharina Hospital Eindhoven, the Netherlands., Gielens MPM; Department of Radiology, Catharina Hospital Eindhoven, the Netherlands., van Bommel RMG; Department of Radiology, Anna Hospital, Geldrop, the Netherlands., van Riet YE; Department of Surgery, Catharina Hospital Eindhoven, the Netherlands., Voogd AC; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands., Nieuwenhuijzen GAP; Department of Surgery, Catharina Hospital Eindhoven, the Netherlands.
Publikováno v: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Sep; Vol. 50 (9), pp. 108472. Date of Electronic Publication: 2024 Jun 05.
Zobrazit plný text záznamu
2
Akademický článek
Efficacy and safety of Anlotinib based neoadjuvant chemotherapy for locally advanced triple negative breast cancer (TNBC).
Autor: Ren, Kuojun1,2 (AUTHOR), Wang, Shuhan1,2 (AUTHOR), Ye, Tingbo1 (AUTHOR), Zhu, Zhengzhi1,2 (AUTHOR), Hong, Shikai1,2 (AUTHOR), Wang, Shengying1,2 (AUTHOR) shengywang@163.com, Liu, Jianjun1,2 (AUTHOR) ljianjun@ustc.edu.cn
Publikováno v: BMC Cancer. 10/7/2024, Vol. 24 Issue 1, p1-8. 8p.
Zobrazit plný text záznamu
3
Akademický článek
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
Autor: de Groot S; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Pijl H; Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands., Charehbili A; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., van de Ven S; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands., Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Meershoek-Klein Kranenbarg E; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Heijns JB; Department of Medical Oncology, Amphia hospital, Breda, The Netherlands., van Warmerdam LJC; Department of Clinical Oncology, Catharina Ziekenhuis, Eindhoven, The Netherlands., Kessels LW; Department of Medical Oncology, Deventer hospital, Deventer, The Netherlands., Dercksen MW; Department of Clinical Oncology, Maxima Medisch Centrum, Veldhoven, The Netherlands., Pepels MJAE; Department of Clinical Oncology, Elkerliek Ziekenhuis, Helmond, The Netherlands., van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Vriens BEPJ; Department of Clinical Oncology, Catharina Ziekenhuis, Eindhoven, The Netherlands., Putter H; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands., Fiocco M; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.; Mathematical Department, Leiden University, Leiden, The Netherlands., Liefers GJ; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., van der Hoeven JJM; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.; Department of Clinical Oncology, Radboud University, Nijmegen, The Netherlands., Nortier JWR; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. j.r.kroep@lumc.nl.
Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2019 Aug 28; Vol. 21 (1), pp. 97. Date of Electronic Publication: 2019 Aug 28.
Zobrazit plný text záznamu
4
Akademický článek
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG).
Autor: Claessens AKM; Department of Medical Oncology, Zuyderland Medical Centre, Dr. H. van der Hoffplein 1, 6162 BG, Geleen, The Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus Medical Centre, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Lopez-Yurda M; Department of Biometrics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Bouma JM; Department of Trial Registration, Comprehensive Cancer Centre the Netherlands, Vasteland 78, 3011 BN, Rotterdam, The Netherlands., Rademaker-Lakhai JM; Dutch Breast Cancer Research Group, BOOG Study Centre, IJsbaanpad 9, 1076 CV, Amsterdam, The Netherlands., Honkoop AH; Department of Medical Oncology, Isala Clinic, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands., de Graaf H; Department of Medical Oncology, Leeuwarden Medical Centre, Henri Dunantweg 2, 8934 AD, Leeuwarden, The Netherlands., van Druten E; Department of Oncologic Research, Reinier de Graaf Hospital, Reinier de Graafweg 5, 8934 AD, Delft, The Netherlands., van Warmerdam LJC; Department of Medical Oncology, Catharina Hospital Eindhoven, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands., van der Sangen MJC; Department of Medical Oncology, Catharina Hospital Eindhoven, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands.; Department of Radiation Oncology, Catharina Hospital Eindhoven, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands., Erdkamp FLG; Department of Medical Oncology, Zuyderland Medical Centre, Dr. H. van der Hoffplein 1, 6162 BG, Geleen, The Netherlands. f.erdkamp@zuyderland.nl.; Department of Internal Medicine - Medical Oncology, Zuyderland Medical Centre, Dr. H. van der Hoffplein 1, 6162 BG, Geleen, The Netherlands. f.erdkamp@zuyderland.nl.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Nov; Vol. 172 (2), pp. 413-423. Date of Electronic Publication: 2018 Aug 18.
Zobrazit plný text záznamu
5
Akademický článek
Predicting breast and axillary response after neoadjuvant treatment for breast cancer: The role of histology vs receptor status.
Autor: Vugts G; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Van den Heuvel F; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Maaskant-Braat AJG; Department of Surgery, Máxima Medical Centre, Veldhoven, The Netherlands., Voogd AC; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Van Warmerdam LJC; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands., Nieuwenhuijzen GAP; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Van der Sangen MJC; Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands.
Publikováno v: The breast journal [Breast J] 2018 Nov; Vol. 24 (6), pp. 894-901. Date of Electronic Publication: 2018 Jul 22.
Zobrazit plný text záznamu
6
Akademický článek
Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer.
Autor: Vriens BEPJ; Division of Medical Oncology, Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands., Vriens IJH; Division of Medical Oncology, Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands., Aarts MJB; Division of Medical Oncology, Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands., van Gastel SM; Comprehensive Cancer Centre the Netherlands, Nijmegen, The Netherlands., van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Centre, Heerlen, The Netherlands., Smilde TJ; Department of Internal Medicine, Jeroen Bosch Hospital, 's Hertogenbosch, The Netherlands., van Warmerdam LJC; Department of Internal Medicine, Catharina-Hospital, Eindhoven, The Netherlands., van Spronsen DJ; Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands., Peer PGM; Biostatistics, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., de Boer M; Division of Medical Oncology, Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands., Tjan-Heijnen VCG; Division of Medical Oncology, Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. vcg.tjan.heijnen@mumc.nl.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2017 Oct; Vol. 165 (3), pp. 593-600. Date of Electronic Publication: 2017 Jul 03.
Zobrazit plný text záznamu
8
Akademický článek
Do topotecan concentrations in saliva reflect plasma concentrations?
Autor: van Warmerdam, Ljc, Rosing, H., ten Bokkel Huinink, WW, Maes, Raa, Beijnen, JH
Publikováno v: Journal of Oncology Pharmacy Practice; Jun1995, Vol. 1 Issue 1, p41-45, 5p
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje